Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 22,499 | 9,734 | 8,360 | 6,355 | 2,986 |
| Gross Profit | 22,499 | 9,734 | 8,360 | 6,355 | 2,986 |
| Operating Expenses | 54,677 | 45,739 | 34,512 | 25,425 | 9,578 |
| Operating Income | -32,178 | -36,005 | -26,152 | -19,070 | -6,592 |
| Other Income | 345 | 1,473 | 660 | 946 | 0 |
| Pre-tax Income | -31,833 | -34,532 | -25,492 | -18,124 | -6,592 |
| Net Income Continuous | -31,833 | -34,532 | -25,492 | -18,124 | -6,592 |
| Net Income | $-31,833 | $-34,532 | $-25,492 | $-18,124 | $-6,592 |
| EPS Basic Total Ops | -4.18 | -5.56 | -10.04 | -7.12 | -2.60 |
| EPS Basic Continuous Ops | -4.18 | -5.55 | -10.00 | -7.11 | -2.59 |
| EPS Diluted Total Ops | -4.18 | -5.56 | -10.04 | -7.12 | -2.60 |
| EPS Diluted Continuous Ops | -4.18 | -5.55 | -10.00 | -7.11 | -2.59 |
| EPS Diluted Before Non-Recurring Items | -4.16 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-30,938 | $-34,930 | $-24,964 | $-18,223 | $-6,413 |